Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study
Autoři:
Andrea O. Y. Luk aff001; Calvin Ke aff001; Eric S. H. Lau aff001; Hongjiang Wu aff001; William Goggins aff005; Ronald C. W. Ma aff001; Elaine Chow aff001; Alice P. S. Kong aff001; Wing-Yee So aff001; Juliana C. N. Chan aff001
Působiště autorů:
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, People’s Republic of China
aff001; Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China
aff002; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China
aff003; Department of Medicine, University of Toronto, Toronto, Canada
aff004; School of Public Health, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, People’s Republic of China
aff005; Hong Kong Hospital Authority, Hong Kong Special Administrative Region, People’s Republic of China
aff006
Vyšlo v časopise:
Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study. PLoS Med 17(2): e32767. doi:10.1371/journal.pmed.1003052
Kategorie:
Research Article
doi:
https://doi.org/10.1371/journal.pmed.1003052
Souhrn
Background
There is very limited data on the time trend of diabetes incidence in Asia. Using population-level data, we report the secular trend of the incidence of type 1 and type 2 diabetes in Hong Kong between 2002 and 2015.
Methods and findings
The Hong Kong Diabetes Surveillance Database hosts clinical information on people with diabetes receiving care under the Hong Kong Hospital Authority, a statutory body that governs all public hospitals and clinics. Sex-specific incidence rates were standardised to the age structure of the World Health Organization population. Joinpoint regression analysis was used to describe incidence trends.
A total of 562,022 cases of incident diabetes (type 1 diabetes [n = 2,426]: mean age at diagnosis is 32.5 years, 48.4% men; type 2 diabetes [n = 559,596]: mean age at diagnosis is 61.8 years, 51.9% men) were included. Among people aged <20 years, incidence of both type 1 and type 2 diabetes increased. For type 1 diabetes, the incidence increased from 3.5 (95% CI 2.2–4.9) to 5.3 (95% CI 3.4–7.1) per 100,000 person-years (average annual percentage change [AAPC] 3.6% [95% CI 0.2–7.1], p < 0.05) in boys and from 4.3 (95% CI 2.7–5.8) to 6.4 (95% CI 4.3–8.4) per 100,000 person-years (AAPC 4.7% [95% CI 1.7–7.7], p < 0.05] in girls; for type 2 diabetes, the incidence increased from 4.6 (95% CI 3.2–6.0) to 7.5 (95% CI 5.5–9.6) per 100,000 person-years (AAPC 5.9% [95% CI 3.4–8.5], p < 0.05) in boys and from 5.9 (95% CI 4.3–7.6) to 8.5 (95% CI 6.2–10.8) per 100,000 person-years (AAPC 4.8% [95% CI 2.7–7.0], p < 0.05) in girls. In people aged 20 to <40 years, incidence of type 1 diabetes remained stable, but incidence of type 2 diabetes increased over time from 75.4 (95% CI 70.1–80.7) to 110.8 (95% CI 104.1–117.5) per 100,000 person-years (AAPC 4.2% [95% CI 3.1–5.3], p < 0.05) in men and from 45.0 (95% CI 41.4–48.6) to 62.1 (95% CI 57.8–66.3) per 100,000 person-years (AAPC 3.3% [95% CI 2.3–4.2], p < 0.05) in women. In people aged 40 to <60 years, incidence of type 2 diabetes increased until 2011/2012 and then flattened. In people aged ≥60 years, incidence was stable in men and declined in women after 2011. No trend was identified in the incidence of type 1 diabetes in people aged ≥20 years. The present study is limited by its reliance on electronic medical records for identification of people with diabetes, which may result in incomplete capture of diabetes cases. The differentiation of type 1 and type 2 diabetes was based on an algorithm subject to potential misclassification.
Conclusions
There was an increase in incidence of type 2 diabetes in people aged <40 years and stabilisation in people aged ≥40 years. Incidence of type 1 diabetes continued to climb in people aged <20 years but remained constant in other age groups.
Klíčová slova:
Age groups – Antigen-presenting cells – Asia – Diabetes diagnosis and management – diabetes mellitus – HbA1c – Hong Kong – Type 2 diabetes
Zdroje
1. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels, Belgium: International Diabetes Federation; 2017.
2. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, et al.; 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults. JAMA. 2013;310: 948–958. doi: 10.1001/jama.2013.168118 24002281
3. Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al.; China National Diabetes and Metabolic Disorders Study Group. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362: 1090–1101. doi: 10.1056/NEJMoa0908292 20335585
4. Quan J, Li TK, Pang H, Choi CH, Siu SC, Tang SY, et al. Diabetes incidence and prevalence in Hong Kong, China during 2006–2014. Diabet Med. 2017;34: 902–908. doi: 10.1111/dme.13284 27859570
5. Census and Statistic Department. Thematic Household Survey Report No. 50. Hong Kong SAR: Census and Statistics Department; 2013 [cited 2019 Oct 18]. https://www.statistics.gov.hk/pub/B11302502013XXXXB0100.pdf
6. American Diabetes Association. Standards of Medical Care in Diabetes– 2010. Diabetes Care. 2010;33 Suppl 1: S11–S61.
7. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20: 1183–1197. doi: 10.2337/diacare.20.7.1183 9203460
8. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G; EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 2009;373: 2027–2033. doi: 10.1016/S0140-6736(09)60568-7 19481249
9. Skrivarhaug T, Stene LC, Drivvoll AK, Strøm H, Joner G; Norwegian Childhood Diabetes Study Group. Incidence of type 1 diabetes in Norway among children aged 0–14 years between 1989 and 2012: has the incidence stopped rising? Results from the Norwegian Childhood Diabetes Registry. Diabetologia. 2014;57: 57–62. doi: 10.1007/s00125-013-3090-y 24149838
10. Haynes A, Bulsara MK, Bower C, Jones TW, Davis EA. Regular peaks and troughs in the Australian incidence of childhood type 1 diabetes mellitus (2000–2011). Diabetologia. 2015;58: 2513–2516. doi: 10.1007/s00125-015-3709-2 26228717
11. Rush T, McGeary M, Sicignano N, Buryk MA. A plateau in new onset type 1 diabetes: Incidence of pediatric diabetes in the United States Military Health System. Pediatric Diabetes. 2018;19: 917–922. doi: 10.1111/pedi.12659 29446519
12. Zhao Z, Sun C, Wang C, Li P, Wang W, Ye J, et al. Rapidly rising incidence of childhood type 1 diabetes in Chinese population: epidemiology in Shanghai during 1997–2011. Acta Diabetol. 2014;51: 947–953. doi: 10.1007/s00592-014-0590-2 24777734
13. Kim JH, Lee CG, Lee YA, Yang SW, Shin CH. Increasing incidence of type 1 diabetes among Korean children and adolescents: analysis of data from a nationwide registry in Korea. Pediatric Diabetes. 2016;17: 519–524. doi: 10.1111/pedi.12324 26420382
14. Huen KF, Low LC, Wong GW, Tse WW, Yu AC, Lam YY, et al. Epidemiology of diabetes mellitus in children in Hong Kong: the Hong Kong childhood diabetes register. J Pediatr Endocrinol Metab. 2000;13: 297–302. 10714755
15. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes. Diabetologia. 2001;44: 914–922. doi: 10.1007/s001250100548 11508279
16. So HK, Nelson EA, Li AM, Wong EM, Lau JT, Guldan GS, et al. Secular changes in height, weight and body mass index in Hong Kong children. BMC Public Health. 2008;8: 320. doi: 10.1186/1471-2458-8-320 18803873
17. Centre for Health Protection. Department of Health. The Government of the Hong Kong Special Administrative Region [Internet]. Centre for Health Protection; 2017 [cited 2019 Apr 12]. Overweight and obesity. https://www.chp.gov.hk/en/statistics/data/10/757/5513.html.
18. Mayer-Davis EJ, Lawrence JM, Dabelea D, Divers J, Isom S, Dolan L, et al.; SEARCH for Diabetes in Youth Study. Incidence trends of type 1 and type 2 diabetes among youths, 2002–2012. N Engl J Med. 2017;376: 1419–1429. doi: 10.1056/NEJMoa1610187 28402773
19. Wu H, Zhong J, Yu M, Wang H, Gong W, Pan J, et al. Incidence and time trends of type 2 diabetes mellitus in youth aged 5–19 years: a population-based registry in Zhejiang, China, 2007 to 2013. BMC Pediatrics. 2017;17: 85. doi: 10.1186/s12887-017-0834-8 28330444
20. Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care. 1993;16: 310–314. doi: 10.2337/diacare.16.1.310 8422798
21. Tam WH, Ma RC, Yang X, Li AM, Ko GT, Kong AP, et al. Glucose intolerance and cardiometabolic risk in adolescents exposed to maternal gestational diabetes: a 15-year follow-up study. Diabetes Care. 2010;33: 1382–1384. doi: 10.2337/dc09-2343 20215448
22. Navas-Acien A, Silbergeld EK, Pastor-Barriuso R, Guallar E. Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA. 2008;300: 814–822. doi: 10.1001/jama.300.7.814 18714061
23. Janus ED, for the Hong Kong Cardiovascular Risk Factor Prevalence Study Group. Epidemiology of cardiovascular risk factors in Hong Kong. Clin Exp Pharmacol Physiol. 1997;24: 987–988. doi: 10.1111/j.1440-1681.1997.tb02736.x 9406673
24. Ko GT, Tang JS, Chan JC. Worsening trend of central obesity despite stable or decline body mass index in Hong Kong Chinese between 1996 and 2005. Eur J Clin Nutr. 2010;64: 549–552. doi: 10.1038/ejcn.2010.49 20332802
25. Department of Health. The Government of the Hong Kong Special Administrative Region. Promoting Health in Hong Kong: A Strategic Framework for Prevention and Control of Non-communicable Diseases [Internet]. Department of Health. The Government of the Hong Kong Special Administrative Region; 2008 [cited 2019 Apr 14]. https://www.change4health.gov.hk/filemanager/common/image/strategic_framework/promoting_health/promoting_health_e.pdf.
26. Doblhammer G, Gumà J. A demographic perspective on gender, family and health in Europe. Springer Open; 2018.
27. Cho NH, Chan JC, Jang HC, Lim S, Kim HL, Choi SH. Cigarette smoking is an independent risk factor for type 2 diabetes: a four-year community-based prospective study. Clin Endocrinol (Oxf). 2009;71: 679–685.
28. Tobacco and Alcohol Control Office. Department of Health. The Government of the Hong Kong Special Administrative Region. 2018[cited 2019 Oct 12]. https://www.taco.gov.hk/t/english/infostation/infostation_sta_01.html.
29. Food and Health Bureau. The Government of the Hong Kong Special Administrative Region. Our Partner for Better Health [Internet]. Food and Health Bureau; 2010 [cited 2019 Oct 12]. https://www.fhb.gov.hk/download/press_and_publications/otherinfo/101231_primary_care/e_strategy_doc.pdf.
30. The Government of the Hong Kong Special Administrative Region. Hong Kong Reference Framework for Diabetes Care for Adults in Primary Care Settings. Food and Health Bureau; 2018 [cited 2019 Oct 12]. https://www.fhb.gov.hk/pho/english/resource/files/RF_DM_full.pdf.
31. HA Statistics [Internet]. Hong Kong Hospital Authority. The Government of the Hong Kong Special Administrative Region; 2019 [cited 2019 Oct 12]. http://www3.ha.org.hk/Data/HAStatistics/MajorReport.
32. Alangh A, Chiu M, Shah BR. Rapid increase in diabetes incidence among Chinese Canadians between 1996 and 2005. Diabetes Care. 2013;36: 3015–3017. doi: 10.2337/dc13-0052 23723356
33. Zghebi SS, Steinke DT, Carr MJ, Rutter MK, Emsley RA, Ashcroft DM. Examining trends in type 2 diabetes incidence, prevalence and mortality in the UK between 2004 and 2014. Diabetes Obes Metab. 2017;19: 1537–1545. doi: 10.1111/dom.12964 28387052
34. Norhammar A, Bodegård J, Nyström T, Thuresson M, Eriksson JW, Nathanson D. Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006–2013. Diabetologia. 2016;59: 1692–1701. doi: 10.1007/s00125-016-3971-y 27189067
35. Geiss LS, Wang J, Cheng YJ, Thompson TJ, Barker L, Li Y, Albright AL, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980–2012. JAMA. 2014;312: 1218–1226. doi: 10.1001/jama.2014.11494 25247518
36. Song SO, Lee Y, Kim DW, Song YD, Nam JY, Park KH, et al. Trends in diabetes incidence in the last decade based on Korean National Health Insurance Claims Data. Endocrinol Metab. 2016;31: 292–299.
37. Lin CC, Li CI, Hsiao CY, Liu CS, Yang SY, Lee CC, et al. Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study. BMC Public Health. 2013;13: 318. doi: 10.1186/1471-2458-13-318 23570503
38. Wang J, Thornton JC, Russell M, Burastero S, Heymsfield S, Pierson RN Jr. Asians have lower body mass index but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr. 1994;60: 23–28. doi: 10.1093/ajcn/60.1.23 8017333
39. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301: 2129–2140. doi: 10.1001/jama.2009.726 19470990
40. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348: 1986–1994. doi: 10.1056/NEJMoa030685 12682352
41. Nowicka P, Santoro N, Liu H, Lartaud D, Shaw MM, Goldberg R, et al. Utility of hemoglobin A(1c) for diagnosing prediabetes and diabetes in obese children and adolescents. Diabetes Care. 2011; 34:1306–1311. doi: 10.2337/dc10-1984 21515842
Článek vyšel v časopise
PLOS Medicine
2020 Číslo 2
- FDA varuje před selfmonitoringem cukru pomocí chytrých hodinek. Jak je to v Česku?
- Prof. Jan Škrha: Metformin je bezpečný, ale je třeba jej bezpečně užívat a léčbu kontrolovat
- Jak souvisí postcovidový syndrom s poškozením mozku?
- Umělá inteligence pomůže s výběrem chřipkových kmenů pro výrobu vakcín
- Proč se v Česku šíří několik „vymýcených“ infekcí najednou? Ptáme se odborníků
Nejčtenější v tomto čísle
- Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study
- Digitally enabled aged care and neurological rehabilitation to enhance outcomes with Activity and MObility UsiNg Technology (AMOUNT) in Australia: A randomised controlled trial
- The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial
- An evaluation of Chile’s Law of Food Labeling and Advertising on sugar-sweetened beverage purchases from 2015 to 2017: A before-and-after study